Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
REMY DURAND Insider Profile
4 Followers
REMY DURAND, CBO at Alpine Immune Sciences, holds 0.00 shares in Alpine Immune Sciences (Ticker: ALPN).
REMY DURAND Alpine Immune Sciences (ALPN)CBO
Alpine Immune Sciences (ALPN)
CBO
Not Ranked
REMY DURAND has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
REMY DURAND does not currently own shares as a corporate insider.
A breakdown of REMY DURAND's holdings
Insider Roles
REMY DURAND does not currently hold a role as a corporate insider.
Roles that REMY DURAND holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by REMY DURAND
REMY DURAND's Trading History
List of latest transactions for each holding click on a transaction to see REMY DURAND's performance on stock
You May Also Like
REMY DURAND insider profile FAQ
What is the percentage of profitable transactions made by REMY DURAND?
The percentage of profitable transactions made by REMY DURAND is ―.
What is the average return per transaction made by REMY DURAND?
The average return per transaction made by REMY DURAND is ―.
What stocks does REMY DURAND hold?
REMY DURAND holds: ALPN stocks.
What was REMY DURAND’s latest transaction?
REMY DURAND latest transaction was an Uninformative Sell of ―.
What was REMY DURAND's most profitable transaction?
REMY DURAND’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is REMY DURAND's role in Alpine Immune Sciences?
REMY DURAND's role in Alpine Immune Sciences is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.